Authors:
MACHADO CM
MACEDO MCA
MEDEIROS RSS
MASSUMOTO C
SILVA ACM
CASTELLI JB
SILVA RL
OSTRONOFF M
DULLEY FL
Citation: Cm. Machado et al., PRIMARY PNEUMOCYSTIS-CARINII PROPHYLAXIS WITH AEROSOLIZED PENTAMIDINEAFTER BONE-MARROW TRANSPLANTATION, Acta haematologica, 99(1), 1998, pp. 54-56
Authors:
MACHADO CM
MACEDO MC
CASTELLI JB
OSTRONOFF M
SILVA AC
ZAMBON E
MASSUMOTO C
CHAMONE DF
DULLEY FL
Citation: Cm. Machado et al., CLINICAL-FEATURES AND SUCCESSFUL RECOVERY FROM DISSEMINATED NOCARDIOSIS AFTER BMT, Bone marrow transplantation, 19(1), 1997, pp. 81-82
Authors:
MACEDO MCMA
PALLOTTA RS
SABOYA R
SILVA RL
DZIK C
LOTERIO H
MASSUMOTO CM
CHAMONE DAF
DULLEY FL
Citation: Mcma. Macedo et al., HIGH-DOSE STEROIDS (HDS), CYCLOSPORINE (CSA) AND METHOTREXATE (MTX) VERSUS CSA AND MTX AS PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE (GVHD) IN HLA IDENTICAL BONE-MARROW TRANSPLANTATION (BMT), Blood, 90(10), 1997, pp. 417-417
Authors:
MACHADO CM
BARBOSA MAS
DAROCHA IF
DIOMEDE BB
MASSUMOTO CM
CHAMONE DAF
DULLEY FL
Citation: Cm. Machado et al., BLOOD CULTURES OBTAINED FROM LONG-TERM CENTRAL VENOUS CATHETERS VERSUS PERIPHERAL VEIN PUNCTURE IN FEBRILE BMT RECIPIENTS, Blood, 90(10), 1997, pp. 4418-4418
Authors:
LIZIARDI DO
MACEDO MCMA
PALLOTTA RS
SILVA RL
SABOYA R
DZIK C
LOTERIO H
MASSUMOTO CM
CHAMONE DAF
DULLEY FL
Citation: Do. Liziardi et al., EARLY WITHDRAWAL OF IMMUNOSUPRESSION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) AS PREVENTION OF RELAPSE IN HEMATOLOGICAL MALIGNANCIES, Blood, 90(10), 1997, pp. 4461-4461
Authors:
MELLO M
TANAKA C
TEIXEIRA JOC
CASTRO CC
CERRI GG
BUCHPIGUEL CA
MASSUMOTO CM
CHAMONE DF
DULLEY FL
Citation: M. Mello et al., EARLY APPROACH TO AVASCULAR NECROSIS OF THE FEMURAL HEAD IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION - PRELIMINARY-RESULTS, Blood, 90(10), 1997, pp. 4467-4467
Authors:
DIOMEDE BB
PALLOTTA RS
MACEDO MCMA
SABOYA R
SILVA RL
DIZIK C
LOTERIO H
MASSUMOTO CM
ROCHA IF
CHAMONE DAF
DULLEY FL
Citation: Bb. Diomede et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) WITHOUT HOSPITAL ADMITTANCE OF THE PATIENT, Blood, 90(10), 1997, pp. 4489-4489
Authors:
PALLOTTA RS
MACEDO MCMA
SABOYA R
DZIK C
SILVA RL
LOTERIO H
MASSUMOTO CM
CHAMONE DAF
DULLEY FL
Citation: Rs. Pallotta et al., ONE-DAY BUSULFAN (BU) AND HIGH-DOSE OF CYCLOPHOSPHAMIDE (CY) AS PREPARATIVE REGIMEN FOR BONE-MARROW TRANSPLANTATION (BMT) IN PATIENTS WITH SEVERE APLASTIC-ANEMIA (SAA), Blood, 90(10), 1997, pp. 4507-4507
Authors:
NOVARETTI MCZ
JENS E
BONIFACIO SL
TAIRA E
LEAO A
SARAIVA ECO
TOKUHO R
MIYAMOTO Y
ALMEIDA MC
DULLEY FL
DORLHIACLLACER PE
CHAMONE DAF
Citation: Mcz. Novaretti et al., EVALUATION OF GRAFT-VERSUS-HOST DISEASE RISK IN ABO, LEWIS AND RH INCOMPATIBLE BONE-MARROW TRANSPLANTS, Blood, 88(10), 1996, pp. 3107-3107
Authors:
MACHADO CM
BOAS LSV
DULLEY FL
MACEDO MC
MASSUMOTO C
CASTELLI JB
MEDEIROS RS
SILVA RL
PANNUTI CS
Citation: Cm. Machado et al., ANTIGENEMIA GUIDED GANCICLOVIR THERAPY IN ALLOGENEIC BMT RECIPIENTS -PREEMPTIVE OR EARLY TREATMENT OF ESTABLISHED CMV DISEASE, Blood, 88(10), 1996, pp. 1684-1684
Authors:
MEDEIROS RSS
OSTRONOFF M
MACEDO MCA
MASSUMOTO C
TORIGOE P
ZAMBORN E
DULLEY FL
DIAS L
DORLHIACLLACER P
CHAMONE DAF
Citation: Rss. Medeiros et al., TREATMENT OF REFRACTORY OR RELAPSED NON-HODGKINS-LYMPHOMAS WITH CLASSIC MOPP (NITROGEN-MUSTARD, VINCRISTINE, PROCARBAZINE AND PREDNISONE), Blood, 86(10), 1995, pp. 3260-3260
Authors:
MACEDO MCMA
DULLEY FL
OSTRONOFF M
MACHADO CM
ZAMBON E
MATSUMOTO C
DORLHIACLLACCER P
CHAMONE DF
Citation: Mcma. Macedo et al., EFFECTIVENESS OF AMPHOTERICIN-B IN LIPID EMULSION FOR TREATING FUNGALSEPTICEMIA IN GRANULOCYTOPENIC PATIENTS, Clinical infectious diseases, 19(2), 1994, pp. 366-367
Authors:
DULLEY FL
MACHADO CM
NOKUI Y
ZAMBON E
MACEDO MCMA
SILVA ACM
BOEHRINGER B
OSTRONOFF M
MASSUMOTO C
CHAMONE DF
Citation: Fl. Dulley et al., TOXOPLASMOSIS IN BONE-MARROW TRANSPLANT RECIPIENTS RELATED TO THE CHANGE OF PNEUMOCYSTIS-CARINII PROPHYLAXIS, Blood, 84(10), 1994, pp. 10000334-10000334
Authors:
MACEDO MCMA
OSTRONOFF M
SILVA R
BOEHRINGER B
ZAMBOM E
CONCHON M
MEDEIROS RS
DULLEY FL
MASSUMOTO C
DORLHIACLLACER PE
POZZI DH
CHAMONE DAF
Citation: Mcma. Macedo et al., STANDARD CHOP WITH REDUCED DOSE OF DOXORUBICIN (MINI-CHOP) FOR ELDERLY PATIENTS WITH INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA (NHL), Blood, 84(10), 1994, pp. 10000644-10000644
Authors:
BOEHRINGER B
DULLEY FL
OSTRONOFF M
MACEDO MCMA
SILVA ACM
MASSUMOTO C
ZAMBON E
SABOYA R
LOTERIO H
CHAMONE DAF
Citation: B. Boehringer et al., PRECOCIOUS WITHDRAWAL OF IMMUNOSUPRESSION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION AS PREVENTION OF RELAPSE IN HEMATOLOGIC MALIGNANCIES, Blood, 84(10), 1994, pp. 10000704-10000704
Authors:
MACEDO MCMA
DULLEY FL
OSTRONOFF M
MACHADO CM
SILVA ACM
MASSUMOTO C
BOEHRINGER B
ZAMBON E
LOTERIO H
DORLHIACLLACER PE
CHAMONE DF
Citation: Mcma. Macedo et al., GANCICLOVIR VS GANCICLOVIR PLUS GM-CSF AS PROPHYLAXIS FOR CMV INFECTION IN ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000713-10000713
Authors:
MACEDO MCMA
DULLEY FL
OSTRONOFF M
BOEHRINGER B
MASSUMOTO C
ZAMBON E
MEDEIROS RS
LOTERIO H
DORLIACLLACER PE
CHAMONE DF
Citation: Mcma. Macedo et al., BUSULFAN, CYCLOPHOSPHAMIDE AND METHYLPREDNISOLONE AS PREPARATIVE REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR SEVERE APLASTIC-ANEMIA (SAA), Blood, 84(10), 1994, pp. 10000713-10000713
Authors:
MACHADO CM
OSTRONOFF M
SILVA ACM
MACEDO MCMA
BOEHRINGER B
ZAMBON E
NUKUI Y
MASSUMOTO C
DORLHIACLLACER PE
CHAMONE DF
DULLEY FL
Citation: Cm. Machado et al., PRIMARY PNEUMOCYSTIS-CARINII PROPHYLAXIS WITH AEROSOLIZED PENTAMIDINEAFTER BONE-MARROW TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000714-10000714
Authors:
OSTRONOFF M
DULLEY FL
BOEHRINGER B
MACEDO MCMA
SILVA ACM
MASSUMOTO C
ZAMBON E
SABOYA R
LOTERIO H
CHAMONE DAF
Citation: M. Ostronoff et al., BUSULFAN AND MELPHALAN (BUS PLUS LPAM) AS PREPARATIVE REGIMENS FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION IN HEMATOLOGIC MALIGNANCIES, Blood, 84(10), 1994, pp. 10000716-10000716
Authors:
ZAGONOVARETTI MC
DULLEY FL
DORLHIACLACER PE
CHAMONE DAF
Citation: Mc. Zagonovaretti et al., USE OF THE GEL TEST TO DETECT MIXED RED-BLOOD-CELL POPULATIONS IN BONE-MARROW TRANSPLANTATION PATIENTS, Vox sanguinis, 65(2), 1993, pp. 161-162